Divergent Views Of Patent Eligibility Give Little Insight
In a very important decision for the biotechnology industry, the Court of Appeals for the Federal Circuit recently reaffirmed its holding that patent claims directed to isolated genes and a method...To view the full article, register now.
Already a subscriber? Click here to view full article